Introduction

CD4
+ helper T cells proliferate and differentiate into effector T cell subsets with specific cytokine phenotypes in response to antigen-specific activation. T helper (Th) cells are traditionally classified as Th1 and Th2 cells based on their cytokine-expression profiles (Mosmann et al., 1989) . In particular, Th1 cells produce IFN-γ, which enhances cellular immunity and is required for the clearance of intracellular organisms. On the other hand, Th2 cells produce IL-4, IL-5, IL-13 and IL-25, which enhance humoral immunity and are important for IgE production, eosinophilic inflammation, and the elimination of helminthic infections (Abbas et al., 1996) . However, recent murine experiments have changed this Th1/Th2 paradigm by demonstrating that CD4 + Th cells can differentiate into Th17 cells, which produce IL-17 and play a crucial role in inflammation and autoimmune diseases (Aggarwal et al., 2003; Cua et al., 2003; Langrish et al., 2005) . In addition, CD4 + CD25 + Foxp3 + regulatory T (Treg) cells have also been described as a distinct subset from Th1 and Th2 cells. Treg cells play an anti-inflammatory role and maintain tolerance to self-components by contact-dependent suppression or by releasing anti-inflammatory cytokines, such as, IL-10 and TGF-β (Ng et al., 2001; Dieckmann et al., 2002; Fontenot et al., 2003; Sakaguchi et al., 2006) . Furthermore, the productions of Th17 and Treg cells appear to be mutually exclusive (Bettelli et al., 2006; Mucida et al., 2007) and therefore, the balance between Treg and Th17 cells may be important during the development of autoimmune diseases (Homey, 2006) .
Recent studies have established that IL-17 re- leased by Th17 cells plays key roles during the pathogenesis of experimental autoimmune encephalitis (Langrish et al., 2005) , rheumatoid arthritis (Kotake, 1999; Cho et al., 2008) , inflammatory bowel disease (Fujino et al., 2003) , psoriasis (Zheng et al., 2007) and uveitis (Amadi-Obi et al., 2007) . However, the role of Th17 and its archetypal cytokine, IL-17, is unclear in transplantation immunity. Some studies have shown that IL-17 is associated with acute allograft rejection. In a rat renal allograft transplantation model, IL-17 mRNA levels were found to peak on postoperative day 5, and then decline (Loong et al., 2002) . Furthermore, the acute rejection of aortic allografts was prevented and cardiac allograft survival was prolonged by neutralizing IL-17 with an IL-17R:IgG-Fc fusion protein (Tang et al., 2001; Li et al., 2006) . Although these data may suggest that Th17 cells potentially impact acute allograft rejection, the cellular source of IL-17, and the nature of Th17 cells during allograft rejection remain unknown.
Accordingly, we first analyzed the dynamic differentiations of Treg, Th17, and other IL-17 + cells, including neutrophils and CD8 + T cells, in the context of murine cardiac transplantations. We then evaluated the significances of Th17/Treg balance during allograft rejection.
Results
Histopathological changes
The extent of coagulative myocyte necrosis (CMN), the most definitive characteristic of ischemic heart injury, was diagnosed in both groups of syngeneic and allogeneic recipients as grade 2 at 3 days and grade 1 at 5 days after transplantation ( Figure 1A and 1B). Furthermore, regardless of transplantation group, at day 3, sections of cardiac grafts showed predominant neutrophil infiltration, regarded as archetypal cells of ischemic reperfusion injury. The grade of acute cellular rejection (ACR) deteriorated with time; grade 1R at day 3 and grade 2R at day 5 after transplantation ( Figure 1C and 1D). Sections of allografts showed characteristic mononuclear cell infiltration during acute cellular rejection. Complete rejection of cardiac allografts occurred at 7.8 ± 0.12 days after transplantation. Histopathological features of cardiac graft recipients were summarized in Figure 1E .
Serial changes in serum levels of cytokines
Serum levels of IL-17 and IFN-γ were quantitated using Bio-Plex Ⓡ kits in untransplanted control B6 mice (day 0), allogeneic (BALB/C → B6) recipients, and syngeneic (B6 → B6) recipients on days 1, 3, and 5 after transplantation (Figure 2 ). To determine whether increased production of IL-17 after cardiac transplantation is alloantigen-specific, we initially evaluated serial changes in the IL-17 serum levels after transplantation and compared the two study groups in this respect. In both allogeneic and syngeneic recipients, serum levels of IL-17 peaked on day 3, which corresponded to grade 2 CMN and grade 1R ACR (308.0 ± 74.9 pg/ml vs. 300.1 ± 63.1 pg/ml for allogeneic and syngeneic recipients, respectively), and these values were significantly greater than in naïve B6 mice (P ＜ 0.05). However, on day 5, allogeneic recipients showed a sustained increase in IL-17 serum levels (285 ± 16.6 pg/ml), which contrasted significantly with that The serum levels of IFN-γ were elevated on the 5 th postoperative day in allogeneic recipients. These changes in IL-17 serum levels suggest IL-17 production in vivo is associated with ischemic reperfusion injury during the early postoperative period and then accompanied by alloimmune responses during acute rejection. *P ＜ 0.05 between the two groups on specific postoperative days.
observed in syngeneic recipients (236.1 ± 11.9 pg/ml) (P ＜ 0.05). As illustrated in Figure 2B , serum levels of IFN-γ did not change significantly with time in syngeneic recipients (P = ns). On the other hand, in allogeneic recipients, serum levels of IFN-γ peaked on day 5 and showed significant elevations over other time points (P ＜ 0.05). The results of this work led us to assume that IL-17 production in vivo is due to neutrophils contributing to ischemic reperfusion injury during the early postoperative period, which is then accompanied by alloimmune responses during acute rejection.
Serial changes in the frequencies of IL-17 + cells and Treg cells among splenocytes
To evaluate this hypothesis, concerning the sequential evolution of IL-17 response after transplantation, we examined the phenotype of IL-17 + splenocytes using flow cytometry. In agreement with our hypothesis, the frequencies of Ly6G + IL-17 + cells (Ly6G + IL-17 + /Ly6G + cells) peaked on day 3 (2.94 ± 1.50 and 4.0 ± 1.35%, respectively for allogeneic and syngeneic recipients), and thereafter decreased in both groups ( Figure 3C , P ＜ 0.05). The mean frequency of Th17 (CD4 + IL-17 + /CD4 + T cells) in naïve B6 mice was 0.32 ± 0.08% ( Figure  3A ). However, after cardiac transplantation, Th17 frequencies peaked on day 5 in allogeneic recipients (P ＜ 0.05). Allogeneic recipients showed high Th17 frequencies on day 5 (1.70 ± 0.20%), which were significantly higher than Th17 frequencies in the syngeneic group at this time (0.98 ± 0.17) (P ＜ 0.05). Allogeneic recipients also showed significantly elevated CD8 + IL-17 + T cell (CD8 + IL-17 + / CD8 + T cells) frequencies on day 5 ( Figure 3B , P ＜ 0.05). Furthermore, allogeneic recipients had a higher mean frequency of CD8 + IL-17 + T cells on day 5 (1.95 ± 0.3%) than syngeneic recipients (1.16 ± 0.2%) (P = 0.063).
Treg cells constituted 4.58 ± 0.2% of CD4 + T cells in naïve B6 mice. The frequencies of Treg cells (CD4 + CD25 + Foxp3 + /CD4 + T cells) increased progressively until day 5 in both syngeneic (6.52 ± 0.3%) and allogeneic (6.19 ± 0.6%) recipients ( Figure 3D , P ＜ 0.05). As shown in Figure 4 To ascertain whether the balance between proinflammatory Th17 and anti-inflammatory Treg is disrupted during acute rejection, the ratio of Th17 to Treg was evaluated. With progression of allograft rejection, allogeneic recipients had higher Th17/Treg ratios, i.e., allogeneic recipients had significantly higher Th17/Treg ratios on day 5 than on days 0 and 1 and also had significantly higher Th17/Treg ratios on day 5 than syngeneic recipients ( Figure 5 ).
Expression of IL-17 in graft-infiltrating cells
To assess longitudinal changes in graft-infiltrating IL-17 + cells after transplantation, we used double immunofluorescent staining and confocal analysis. It was found that neutrophils (Ly6G + ; Figure 6A -C), CD4 + T cells ( Figure 6D-F) , and CD8 + T cells ( Figure 6G -I) were IL-17-positive. In both syngeneic and allogeneic grafts, Ly6G + cells highly expressed IL-17 during the early postoperative period. In allogeneic grafts, on days 3 and 5, 13.1 ± 1.3% and 9.3 ± 1.2% of graft-infiltrating Ly6G + cells expressed IL-17, respectively. Likewise, in syngeneic grafts, 12.3 ± 1.1% and 5.9 ± 0.5% of graft-infiltrating Ly6G + cells expressed IL-17. Graftinfiltrating Th17 and CD8 + IL-17 + T cells were identified only in allografts. Th17 cells (9.1 ± 1.3% of CD4
+ T cells) were demonstrated only on day 3, which corresponded to early acute rejection. In accord with our flow cytometry results, CD8 + as well as CD4 + T cells labeled for IL-17 during the acute rejection period. CD8 + T cells expressed IL-17 on day 3 (13.3 ± 0.9%) and day 5 (11.7 ± 1.9%). 
Discussion
The role of Th1 and Th2 cells in acute allograft rejection has been widely investigated and the Th1/Th2 model has been used as a framework to explain the mechanism involved. Increased production of IFN-γ, a prototypic cytokine of Th1 response, and mononuclear cell infiltration of the graft are commonly associated with acute allograft rejection. Thus, Th1 cells are generally considered to be the main mediators of allograft rejection (Chan et al., 1995) . On the other hand, Th2 cells 
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Longitudinal changes in graft-infiltrating cells after transplantation were assessed with double immunofluorescent staining and confocal analysis. With progression of rejection, allografts showed the relative predominance of CD8 + T cells. were initially predicted to promote unresponsiveness and to be associated with the induction of transplant tolerance. However, Th2-mediated rejection has been also reported to be involved in allograft rejection through graft infiltration by eosinophils, especially under conditions in which IFN-γ is depleted (Martinez et al., 1993; Bishop et al., 2001 ). However, this Th1/Th2 paradigm has been recently challenged by the finding that IL-17 is associated with allograft rejection, which suggests that Th17 may participate in transplant immunity (Van Kooten et al., 1998; Tang et al., 2001; Loong et al., 2002; Li et al., 2006) . Furthermore, it has been reported that IL-17 is produced by Th17, . The Th17/Treg balance was disrupted with progression of allogeneic cardiac graft rejection. The ratio of Th17 to Treg cells were calculated using flow cytometric data of splenocytes in syngeneic and allogeneic murine cardiac transplant recipients. Allogeneic recipients showed higher Th17/Treg ratio on day 5 than on day 0 and day 1. On the 5th postoperative day, allogeneic recipients also had significantly higher Th17/Treg ratios than syngeneic recipients. *P＜ 0.05.
natural killer, natural killer T, γδ T, and CD8 + T cells, and even by neutrophils (Kryczek et al., 2007; Weaver et al., 2007; Hoshino et al., 2008) . Yuan and colleagues reported that CD4Th17 cells mediate accelerated vascular rejection and vasculopathy in T-bet -/-mice which exhibit profound deficiency in Th1 response (Yuan et al., 2008) . Thus, it would appear that the cellular source of IL-17 and the dynamics of IL-17-producing cells should be investigated in a wild-type transplantation model without pre-conditioning.
In the present study, we initially evaluated changes in IL-17 serum levels after cardiac transplantation in syngeneic and allogeneic recipients. In agreement with previous studies (Hsieh et al., 2001; Loong et al., 2002) , we found that the serum level of IL-17 peaked on day 3 and declined thereafter in both recipient types (Figure 2A ). However, on day 5, allogeneic recipients showed a continuously increased serum level of IL-17 whereas syngeneic recipients did not. This finding suggests that IL-17 is produced by innate immunity during the early postoperative period, and that IL-17 production is enhanced by allogeneic immunity during allograft rejection. To confirm this hypothesis, we analyzed the phenotype of IL-17 + splenocytes by flow cytometry. On day 3, Ly6G + cells were found to express IL-17 highly in both syngeneic and allogeneic recipients. However, on day 5, in contrast to syngeneic recipients, allogeneic recipients showed a high proportion of Th17 and CD8 + IL-17 + T cells (Figure 3) . Interestingly, IL-17 expression was comparable in CD4 + and CD8 + T cells in allogeneic recipients. Thus, our findings lead us to conclude that neutrophils that contribute to ischemic reperfusion injury produce mainly IL-17 during the early postoperative period and that CD8 + as well as CD4 + T cells secrete IL-17 during acute allograft rejection due to an adaptive immune response.
The second important finding of the present study arose from double-labeling confocal analysis. Specifically, IL-17 + cells were found to contain a rather higher proportion of Ly6G + , CD4 + and CD8 + T cells in grafts (up to 15%) than in spleen, which may have been due to the in vivo microenvironment. Similar results have been reported by Tzartos et al. (2008) in a study on multiple sclerosis (MS) in which IL-17 + T cells were found to be associated with increased activity in MS lesion, and reported by Korn et al. (2007) in an experimental allergic encephalitis model, in which IL-17 + cells were detected in the inflamed CNS, but not in the draining lymph nodes. In the present study, CD8
+ IL-17 + T cells were identified for up to 5 days in allografts after cardiac transplantation, whereas Th17 cells were detected only on day 3 (Table 1) . This contradicts an observation by Langrish et al. (2005) that IL-17 + cells were mainly composed of CD4 + T cells in an EAE model. This apparent difference may be due to the relative predominance of CD8 + T cells during cardiac allograft rejection (Burrell et al., 2008) .
It has been reported that there is a dichotomy in the generation of Th17 that induces autoimmunity and Treg that inhibits autoimmune tissue injury (Bettelli et al., 2006; Mucida et al., 2007) . Thus, the balance between Th17 and Treg cells may be important in induction or regulation of tissue inflammation. This leads to the third major finding of the present study; we demonstrated for the first time that Th17/Treg balance is disrupted during allograft rejection. We observed that the frequencies of Th17 ( Figure 3A ) and Treg cells ( Figure 3D ) among CD4 + T cells gradually and concomitantly increased after cardiac transplantation in both allogeneic and syngeneic recipients, but that the Th17/Treg ratio on day 5 was significantly higher in allogeneic than in syngeneic recipients ( Figure 5 ). This suggests that the disruption of the balance between Th17 and Treg is associated with the development of allograft rejection, as well. Similarly, Cheng et al. (2008) also found that a Th17/Treg functional imbalance exists in patients with acute coronary syndrome (including unstable angina and acute myocardial infarction).
Finally, Benghiat et al. (2008) reported that Th17 cells could be part of CD25 + memory T cells and that isolation of nTregs solely on CD25 expression may lead to undesired selection of them. Likewise, in the present study, a considerable amount of Th17 cells were found to be positive for CD25, which is also a marker for activated T cells, whereas Foxp3 + Tregs were found to scarcely express IL-17 ( Figure  4) . However, as CD4 + CD25 + Foxp3 + regulatory T cells can induce CD4 + CD25-Foxp3 -T cells to become Th17 cells and can differentiate into Th17 cells (Xu et al., 2007) , close attention should be paid to the selection of Tregs and also to the development of the Th17 responses during Tregs-based immunotherapy.
Altogether, the present study demonstrates the dynamic differentiation of IL-17-producing cells, including Ly6G + (neutrophils), CD4 + and CD8 + T cells in the context of allograft rejection, in a wild-type murine cardiac transplant model. We found that neutrophils produce IL-17 during the early postoperative period and that CD8 + as well as CD4 + T cells produce IL-17 during allograft rejection. In addition, our findings also demonstrate that IL-17 + cells contain higher proportions of Ly6G + cells, CD4 + and CD8 + T cells in cardiac grafts than in spleens. Finally, Th17/Treg ratios were found to be significantly higher during allograft rejection, which suggests that Th17 to Treg imbalance plays a role in the development of allograft rejection. To draw firm conclusion, however, it needs an allograft transplantation model where only some of the recipients accept the graft. The Th17/Treg balances between allogeneic acceptor and rejector groups would be compared to test whether the balance is disrupted in the rejector group. In spite of an observational study, this study would provide basic information on Th17 biology in transplant immunity, which needs further investigation.
Methods
Mice
Female C57BL/6 (B6, H-2b) and BALB/C (H-2d) mice were purchased from Japan SLC (Kotoh-cho, Japan), and housed in a specific pathogen-free animal facility. Mice were routinely used at about 8 weeks of age. This study was approved by Institutional Animal Care and Use Committee (IACUC) of the Clinical Research Institute at Seoul National University Hospital. This facility is accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International.
Heterotopic cardiac transplantation
For allogeneic transplantations, BALB/C and B6 mice were used as donors and recipients (the allogeneic group), respectively, and for syngeneic transplantations group, B6 mice were used as donors and recipients (the syngeneic group). Heterotopic cardiac transplantations were performed with microsurgical technique in a similar manner as previously described (Corry et al., 1973; Niimi, 2001) . Briefly, donor hearts were harvested after cool perfusion with heparinized lactated Ringer's solution and then placed into cooled lactated Ringer's solution while the recipients were prepared for transplantation. The graft aorta was anastomosed to the recipient abdominal aorta and the graft pulmonary artery was anastomosed to the recipient inferior vena cava. Effective ventricular contraction usually occurred within 30 s after reperfusion.
Histology
Cardiac grafts were recovered at several time points after transplantation, fixed in formalin, paraffin embedded, serially sectioned at 4 μm, and stained with H&E by routine technique. At least two separate slides were examined to assess myocyte viability and acute rejection. The extent of coagulative myocyte necrosis (CMN), which is the most definitive manifestation of ischemic myocyte injury, was graded semiquantitatively (Fyfe et al., 1996; Tan et al., 2007) : grade 0, no evidence of CMN; grade 1, mild (focal) CMN; grade 2, moderate (multifocal) CMN; and grade 3, severe (confluent) CMN. Acute cellular rejection (ACR) was graded according to the criteria proposed by the International Society for Heart and Lung Transplantation (ISHLT) (Stewart et al., 2005) , as follows: grade 1R, mild ACR; grade 2R, moderate ACR; and grade 3R, severe ACR, regardless of the presence or absence of CMN on slides. All the slides were examined by single pathologist.
Cytokine levels
Circulating levels of IL-17 and IFN-γ were quantified in mouse serum using the Bio-Plex Ⓡ Cytokine Assay 18-Plex kit (BioRad Laboratories, Hercules, CA) and the Bio-Plex 200 platform, according to the manufacturer's instructions.
Flow cytometry analysis
Spleens were retrieved, mashed, and then erythrocytes were lysed using an RBC lysing buffer. Splenocytes were first stained extracellularly with anti-mouse CD3 APC, anti-mouse CD4 PE, anti-mouse CD8 PECy7, anti-mouse CD25 PECy7, anti-mouse CD45 APC, anti-mouse Ly6G PE, and appropriate isotype control mAb (BD Pharmingen, San Jose, CA), as per manufacturer's instructions. After surface staining, cells were fixed and permeabilized with Fixation/Permeabilization solution (BD Pharmingen), and then stained intracellularly with anti-mouse IL-17 FITC and anti-mouse Foxp3 APC (eBioscience, San Diego, CA), according to the manufacturer's protocol. Cell analysis was performed using a FACScan cytometer equipped with CellQuest software (BD Bioscience).
Immunofluorescent staining and confocal analysis
For immunostaining, cardiac grafts were recovered at several time points after transplantation and embedded in OCT compound (Sakura Finetechnical Co., Tokyo, Japan), and then snap-frozen in liquid nitrogen. Frozen sections (4 μm) were fixed in acetone for 10 min and air-dried. Slides were stained with anti-mouse Ly6G Alexa 647 (BioLegend, San Diego, CA), anti-mouse CD4 Pacific Blue, anti-mouse CD8 Alexa 488 (BD Pharmingen), and anti-mouse IL-17 PE (eBioscience) for direct immunofluorescent staining, and then analyzed with a LSM 5 Image Browser using an LSM 510 META confocal laser scanning microscope (Zeiss, Jena, Germany). Areas which showed the most extensive infiltration of inflammatory cells were selected and images were acquired at high-power (×400) using a confocal microscope. The CD4 + , CD8 + , Ly6G + , and IL-17 + cells were counted in each image using ImageJ software (National Institutes of Health, Bethesda, MD). The percentages of IL-17 + cells with respect to CD4 + , CD8 + , and Ly6G + cells were calculated using double immunofluorescent data. A second 'blind' observer re-determined percentages using the same images.
Statistical analysis
Statistical analysis was performed using SPSS software version 15.0 for Windows (SPSS, IL). Data are presented as mean ± SEM and analyzed using the Mann-Whitney and Kruskal-Wallis tests. A P value ＜ 0.05 was considered to be statistically significant.
